Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 57Other solid neoplasm 57Sarcoma 2Gynecologic 2Gastrointestinal 2Breast 2Lymphoid 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 92Triple Negative Breast Neoplasms 38Neoplasm Metastasis 11Carcinoma, Non-Small-Cell Lung 9Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Colorectal Neoplasms 6Melanoma 5Cholangiocarcinoma 5Sarcoma 4Prostatic Neoplasms 4Lung Neoplasms 4Inflammatory Breast Neoplasms 4Breast Neoplasms, Male 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Gallbladder Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma, Ductal, Breast 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Mesothelioma, Malignant 2Mesothelioma 2Lymphoma, Non-Hodgkin 2Lymphoma 2

Interventions

pembrolizumab 2Cyclophosphamide 2Cisplatin 2sargramostim 1regorafenib 1fludarabine 1entinostat 1durvalumab 1cemiplimab 1avelumab 1atezolizumab 1abemaciclib 1Surgical Procedures, Operative 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Pemetrexed 1Paclitaxel 1Nivolumab 1Midazolam 1Microarray Analysis 1Megestrol Acetate 1Levoleucovorin 1Leucovorin 1Letrozole 1LY3023414 1Interleukin-2 1Interferon-gamma 1Interferon-alpha 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Cisplatin × Breast × Clear all
NCT04491942 2026-04-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
74 enrolled
BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

NCT01655225 2022-04-08

A Study of LY3023414 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
156 enrolled
BreastLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡